FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/05/066948 [Registered on: 07/05/2024] Trial Registered Prospectively
Last Modified On: 03/04/2026
Post Graduate Thesis  No 
Type of Trial  Interventional 
Type of Study   Other (Specify) [Diet, Yoga and sleep pattern]  
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   Comparative analysis of composite lifestyle intervention and conventional methods in managing obese PCOS related hormonal and weight, stress in subjects with PCOS. 
Scientific Title of Study   A randomized, Single center, Single-blind, Parallel, Two-Arm, Comparative analysis of composite lifestyle intervention and conventional methods in managing obese PCOS related hormonal and metabolic parameters in subjects with PCOS. 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
Observation Study  ClinicalTrials.gov 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Sakthivel 
Designation  Consultant Endocrinologist 
Affiliation  Hormone Clinic 
Address  Hormone Clinic Sivasakthi nursing home Thillainagar Trichy

Tiruchirappalli
TAMIL NADU
620018
India 
Phone  8508284662  
Fax    
Email  revathi890ph@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Sakthivel 
Designation  Consultant Endocrinologist 
Affiliation  Hormone Clinic 
Address  Hormone Clinic Sivasakthi nursing home Thillainagar Trichy

Tiruchirappalli
TAMIL NADU
620018
India 
Phone  8508284662  
Fax    
Email  revathi890ph@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Ms Dheeptha Sundar 
Designation  Clinical Dietician 
Affiliation  Hormone Clinic 
Address  Hormone Clinic Sivasakthi nursing home Thillainagar Trichy

Tiruchirappalli
TAMIL NADU
620018
India 
Phone  8610269340  
Fax    
Email  sabarinathan200107@gmail.com  
 
Source of Monetary or Material Support  
Hormone Clinic, Sivasakthi nursing home, Thillainagar, Tiruchirappalli, Tamilnadu, India-620018 
 
Primary Sponsor  
Name  DrSakthivel 
Address  Hormone Clinic, Sivasakthi nursing home, Thillainagar, Trichy 
Type of Sponsor  Other [Self] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Sakthivel  Hormone Clinic  1, Second floor, Endocrinology department, Hormone clinic, Sivasakthi Nursing Home, Thillainagar, Tiruchirappalli-620018.
Tiruchirappalli
TAMIL NADU 
8508284662

revathi890ph@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee - Athma Hospital  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: E282||Polycystic ovarian syndrome,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  Conventional   The subject will involve in existing PCOS medications 
Intervention  Life style modification  The subjects will involve in Proper Diet, Sleep pattern, Yoga and exercise plan 
 
Inclusion Criteria  
Age From  20.00 Year(s)
Age To  40.00 Year(s)
Gender  Female 
Details  ï‚·Age Range: Participants aged 20 to 40 years (inclusive). Subject must meet age requirements at the time of signing the initial study specific informed consent. In addition, the subject’s race and ethnicity should be documented.
ï‚·Gender: Females, Non-Pregnant or Non-lactating Female and Child bearing potential women
Women of Child bearing potential must have a negative serum beta human chorionic gonadotropin (β-HCG) pregnancy test performed within 28 days prior to the randomization.
ï‚·Women of child barring potential are to be subjected to contraceptive techniques to refrain from pregnancy via oral, hormonal, or other contraceptive methods.
ï‚·Diagnosis of PCOS: Participants must have a confirmed diagnosis of PCOS based on established criteria (e.g., Rotterdam criteria). Hypothyroid adequately replaced.
Controlled Diabetic, Pre diabetes and non diabetic females are considered for the study (hbA1c≤8)
Body Mass Index (BMI):Each subject should have a Body mass index (BMI)value less than or equal to 35.0kg/m2 but greater than 23.0kg/m2. All weight values are to be reported according to the scale’s precision (I.e. the nearest tenth or hundredth 72.3 kg or 72.25kg). The subject’s height is to be reported in centimeters near to tenth. Each subject’s BMI is to be calculated using the reported weight in kilograms and height in centimeters and it is should be reported to the nearest tenth (I.e. 26.3kg/m2)
ï‚·Sleep routine: sleep cycle should be at least 5 to 8 hours/ day.
ï‚·Smoking status: The subject should be non-smokers, non-alcoholic or not using any smoking or alcohol or any tobacco related products for more than a year.
ï‚·Willingness to Participate: Individuals willing to follow the protocol requirements and comply with protocol restrictions.
ï‚·Consent: Participants should have adequate decision-making ability to make a choice about participating in this study and provide written informed consent to participate.
ï‚·All the candidates are to be examined by the chief medical practitioner and other parameters corresponding to the clinical diagnosis are evaluated.
ï‚·If warranted other tests or examinations can be done at the discrepancy of the investigator. 
 
ExclusionCriteria 
Details  ï‚·Age: Adult women in the age group of 20 to 40 who pregnant.
ï‚·Pregnancy and Lactation:
ï‚·Participants who are currently pregnant or planning to become pregnant during the study period.
ï‚·Participants who are currently lactating.
ï‚·B- HCG positive within 15 days of start of study or prestudy medical examination are to be excluded
Menopausal Status: Women in menopause. 
 
Method of Generating Random Sequence   Permuted block randomization, fixed 
Method of Concealment   An Open list of random numbers 
Blinding/Masking   Participant Blinded 
Primary Outcome  
Outcome  TimePoints 
The primary outcome of the study will recruit the 120 subjects to assess the PCOS hormonal parameters at 24 weeks  This study was undertaken to explore the influence and thyroid function, insulin resistance, body weight, BMI, and lipid profile as secondary outcomes. 
 
Secondary Outcome  
Outcome  TimePoints 
This study was undertaken to explore the influence & enhancement of thyroid function, insulin resistance, body weight, BMI, & lipid profile as secondary outcomes at 12 weeks  The assessment of improvements in inflammatory response, sleep patterns, subjective well-being scores, skin, & hair conditions (specifically hirsutism), & parameters associated with menstruation such as stomach pain, abdominal bloating, & period cramps were considered as secondary measures. 
 
Target Sample Size   Total Sample Size="120"
Sample Size from India="120" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 3 
Date of First Enrollment (India)   21/05/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)
Modification(s)  
Other (Terminated) 
Recruitment Status of Trial (India)  Other (Terminated) 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

STUDY DRUG: Conventional Method: Any Oral PCOS drugs Interventional Method: Lifestyle Modification (Diet, Yoga, Exercise and Sleep) The innovator and/or inventional method may contain Diet (proper diet chart which is given by dietician), Yoga and exercise and sleep pattern In the conventional method, the participant will take any Oral PCOS drugs to treat their PCOS with regular food chart with regular activities. 

 
Close